Clinical Trials Directory

Trials / Sponsors / Shanxi Province Cancer Hospital

Shanxi Province Cancer Hospital

Academic / Other · 12 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingOsimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib
Lung Cancer (NSCLC), Lung Cancer (Non-Small Cell), Advanced Non-small-cell Lung Cancer
Phase 1 / Phase 22026-05-15
RecruitingPhase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sar
Sarcoma,Soft Tissue, Sarcoma, Sarcoma of Bone
Phase 22024-08-01
CompletedMDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy
Small Cell Lung Cancer, Extensive-Stage Small Cell Lung Cancer, Lung Neoplasms
N/A2024-07-01
UnknownImmune Function of Colorectal Cancer Lymph Nodes
Colorectal Cancer, Lymph Node
—2024-04-01
Not Yet RecruitingA Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Di
Mantle Cell Lymphoma
Phase 22024-03-15
CompletedFamily-Supported Palliative Care in Advanced Lung Cancer
Advanced Lung Cancer, Non-Small Cell Lung Cancer, Lung Neoplasms
N/A2024-01-01
UnknownA Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Me
Urothelial Carcinoma
Phase 22023-08-03
CompletedEvidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer
Advanced Lung Cancer, Cancer-related Fatigue
N/A2023-01-01
UnknownTargeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 1 / Phase 22021-01-22
UnknownTargeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic
Acute Lymphocytic Leukemia， B-Cell
Phase 1 / Phase 22021-01-15
UnknownTargeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma
Lymphoma, B-Cell
Phase 1 / Phase 22021-01-04
UnknownApatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer
Brain Metastases
Phase 22017-12-01